MergerLinks - Request Credit - Ipsen completed the acquisition of Epizyme for $247m.

Submit Deal

Request Deal Involvement

Ipsen completed the acquisition of Epizyme for $247m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

financial advisors

MTS Health Partners

financial advisors

Jefferies & Company

legal advisors

WilmerHale

legal advisors

Orrick Herrington & Sutcliffe

financial advisors

Barclays

legal advisors to financial advisors

Cooley

Principals

target

EPIZYME

bidder

IPSEN

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.

To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal: